PHILADELPHIA — Novel abnormalities in the FGFR gene, called FGFR fusions, were identified in a spectrum of cancers, and preliminary results with cancer cells harboring FGFR fusions suggested that some patients with these cancers may benefit from...
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, Cancer Discovery, Dr. Arul M. Chinnaiyan, gene fusion, The Cancer Genome Atlas, pazopanib, MI-ONCOSEQ, FGFR, PD173074